Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials-Reference-Cited by-同舟云学术

Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials

Published:2020-11-04 Issue:11 Volume:17 Page:e1003323
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Danziger Samuel A.^ORCID,McConnell Mark^ORCID,Gockley Jake^ORCID,Young Mary H.^ORCID,Rosenthal Adam,Schmitz Frank^ORCID,Reiss David J.,Farmer Phil^ORCID,Alapat Daisy V.,Singh Amrit^ORCID,Ashby Cody^ORCID,Bauer Michael^ORCID,Ren Yan,Smith Kelsie^ORCID,Couto Suzana S.,van Rhee Frits^ORCID,Davies Faith,Zangari Maurizio,Petty Nathan,Orlowski Robert Z.,Dhodapkar Madhav V.,Copeland Wilbert B.^ORCID,Fox Brian,Hoering Antje^ORCID,Fitch Alison,Newhall Katie,Barlogie Bart^ORCID,Trotter Matthew W. B.,Hershberg Robert M.,Walker Brian A.^ORCID,Dervan Andrew P.^ORCID,Ratushny Alexander V.^ORCID,Morgan Gareth J.^ORCID

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference47 articles.

1. A new initiative on precision medicine;FS Collins;N Engl J Med,2015

2. Trends in overall survival and costs of multiple myeloma, 2000–2014;R Fonseca;Leukemia,2017

3. Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma;MA Attal;N Engl J Med,2017

4. The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myeloma;CK Stein;Oncotarget,2017

5. The molecular characterization and clinical management of multiple myeloma in the post-genome era;Y Zhou;Leukemia,2009

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple myeloma exosomal miRNAs suppress cGAS-STING antiviral immunity;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-12

2. Construct prognostic models of multiple myeloma with pathway information incorporated;PLOS Computational Biology;2024-09-10

3. Characterization of driver mutations identifies gene signatures predictive of prognosis and treatment sensitivity in multiple myeloma;The Oncologist;2024-09-09

4. Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomas;2024-08-27

5. Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomas;2024-08-27